Pyronaridine

Pyronaridine
Clinical data
Routes of
administration
Oral, intramuscular injection, intravenous therapy
ATC code none
Legal status
Legal status
  • CLP (EU): Acute Tox. 3(H301), Eye Dam. 1 (H318), Repr. 2 (H361), Aquatic Chronic 4 (H413)
Identifiers
CAS Number 74847-35-1 N
PubChem (CID) 5485198
ChemSpider 10647812 YesY
UNII TD3P7Q3SG6 YesY
ChEMBL CHEMBL35228 YesY
Chemical and physical data
Formula C29H32ClN5O2
Molar mass 518.05 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Pyronaridine is an antimalarial drug. It was first synthesized in 1970 and has been in clinical use in China since the 1980s.[1]

It is one of the components of the artemisinin combination therapy pyronaridine artesunate (Pyramax).

References

  1. Chang C, Lin-Hua T, Jantanavivat C (1992). "Studies on a new antimalarial compound: pyronaridine". Trans R Soc Trop Med Hyg. 86 (1): 7–10. doi:10.1016/0035-9203(92)90414-8. PMID 1566313.


This article is issued from Wikipedia - version of the 10/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.